Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, we have started a prospective, ongoing international registry for recording demographics and outcomes for patients undergoing surgical treatments for BPH.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
International Prostate Symptom Score (IPSS)
Timeframe: 36 months
Quality of Life (QoL)
Timeframe: 36 months
Post-Void Residual (PVR)
Timeframe: 36 months
Complications (including incontinence)
Timeframe: 36 months